Get the Stockscreener App
1.99
0.00%
0.00
After Hours:
1.99
Cardio Diagnostics Holdings Inc stock is traded at $1.99, with a volume of 28,641.
It is up +0.00% in the last 24 hours and up +1.53% over the past month.
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases and associated comorbidities by leveraging its Artificial Intelligence (AI)-driven Multi-Omics Engine. The company has developed two clinical products: Epi+Gen CHD and PrecisionCHD, epigenetics-based clinical blood tests capable of assessing risk for a coronary heart disease (CHD) event, including heart attacks. Additionally, its portfolio includes HeartRisk, a cardiovascular disease risk intelligence platform, and CardioInnovate360, a research-use-only solution launched to support the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases.
See More
Previous Close:
$1.99
Open:
$1.99
24h Volume:
28,641
Relative Volume:
0.42
Market Cap:
$5.89M
Revenue:
$16,600
Net Income/Loss:
$-6.65M
P/E Ratio:
-0.5896
EPS:
-3.3752
Net Cash Flow:
$-6.32M
1W Performance:
-4.33%
1M Performance:
+1.53%
6M Performance:
-32.66%
1Y Performance:
-47.63%
1-Day Range:
$1.94
$2.08
1-Week Range:
$1.93
$2.27
52-Week Range:
$0.97
$7.91
Cardio Diagnostics Holdings Inc Stock (CDIO) Company Profile
Name
Cardio Diagnostics Holdings Inc
Sector
Industry
Phone
855-226-9991
Address
311 W. SUPERIOR STREET, CHICAGO
Compare CDIO vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDIO
Cardio Diagnostics Holdings Inc
|
1.99 | 6.48M | 16,600 | -6.65M | -6.32M | -3.3752 |
VRTX
Vertex Pharmaceuticals Inc
|
529.59 | 126.07B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
649.81 | 65.37B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
916.80 | 57.70B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
313.04 | 40.19B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
189.99 | 39.82B | 742.00K | -1.37B | -1.07B | -7.0731 |
Cardio Diagnostics Holdings Inc Stock (CDIO) Latest News
Cardio Diagnostics Holdings (CDIO) Showcases Precision Cardiovascular Solutions for Employers, Health Plans - NewMediaWire
Cardio Diagnostics Highlights Precision Cardiovascular Tools for Employers and Health Plans at National Conferences - citybuzz -
Cardio Diagnostics Holdings (NASDAQ: CDIO) Leverages Epigenetics to Reveal Hidden Heart Disease Risks - TradingView
Cardio Diagnostics Uses Epigenetics to Uncover Hidden Heart Disease Risks - MEXC
Cardio Diagnostics Holdings (CDIO) Brings Molecular Precision to a Blind Spot in Coronary Heart Disease Detection - Yahoo Finance
Cardio Diagnostics Holdings (NASDAQ: CDIO) Brings Molecular Precision to a Blind Spot in Coronary Heart Disease Detection - TipRanks
Cardio Diagnostics Unveils Molecular Test to Address Blind Spots in Coronary Heart Disease Detection - citybuzz -
Cardio Diagnostics Holdings Inc. Actuals & Estimates (NASDAQ:CDIO) - TradingView
Cardio Diagnostics Holdings (CDIO) Expands Coverage of Precision Cardiovascular Tests Through Atlas Healthcare Physicians - Yahoo Finance
Cardio Diagnostics Holdings (NASDAQ: CDIO) Expands Coverage of Precision Cardiovascular Tests Through Atlas Healthcare Physicians - TradingView
Atlas Healthcare will cover Cardio Diagnostics heart tests for members - Stock Titan
Cardio Diagnostics Company Profile & Introduction - Moomoo
Cardio Diagnostics Holdings (CDIO) Targets a $393B Heart Disease Problem With Epigenetics and AI - Yahoo Finance
Cardio Diagnostics Holdings (NASDAQ: CDIO) Targets a $393B Heart Disease Problem with Epigenetics and AI - TradingView
Cardio Diagnostics Targets $393 Billion Heart Disease Problem with Epigenetics and AI - citybuzz -
Cardio Diagnostics Holdings Inc (CDIOW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CDIO Should I Buy - Intellectia AI
Cardio Diagnostics Holdings Inc (CDIOW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Cardio Diagnostics Holdings Inc - TradingKey
Cardio Diagnostics Holdings Inc (CDIOW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cardio Diagnostics Holdings (CDIO) Aligns With Growing Shift Toward Predictive, Precision Medicine - NewMediaWire
Cardio Diagnostics Holdings (NASDAQ: CDIO) Aligns with Growing Shift Toward Predictive, Precision Medicine - TipRanks
Cardio Diagnostics Holdings Inc (CDIO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Cardio Diagnostics Pursues Predictive Precision Medicine to Reduce Heart Disease Burden - citybuzz -
Cardio Diagnostics Holdings Inc (CDIO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cardio Diagnostics Holdings (NASDAQ: CDIO) Working to Help Employers Tackle Cardiovascular Risk, Healthcare Costs - The Globe and Mail
Cardio Diagnostics Holdings (CDIO) Working to Help Employers Tackle Cardiovascular Risk, Healthcare Costs - Yahoo Finance
Cardio Diagnostics Holdings Inc (CDIOW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Cardio Diagnostics Holdings Inc (CDIOW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Cardio Diagnostics Holdings Inc (CDIOW) Institutional Confidence - TradingKey
Cardio Diagnostics Holdings Inc (CDIOW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cardio Diagnostics Holdings Inc (CDIOW) Valuation: PE, PB & Fair Value Analysis - TradingKey
Cardio Diagnostics Holdings Inc (CDIO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cardio Diagnostics Holdings Inc (CDIO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Cardio Diagnostics Holdings Inc (CDIO) Valuation: PE, PB & Fair Value Analysis - TradingKey
Cardio Diagnostics Holdings Inc (CDIO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Cardio Diagnostics Holdings Inc (CDIO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cardio Diagnostics Holdings (NASDAQ: CDIO) Working to Help Employers Tackle Cardiovascular Risk, Healthca - Benzinga
Cardio Diagnostics (CDIO) Harnesses AI, Genetics and Epigenetics to Advance Cardiovascular Risk Detection - NewMediaWire
Cardio Diagnostics (NASDAQ: CDIO) Harnesses AI, Genetics and Epigenetics to Advance Cardiovascular Risk Detection - TipRanks
Caristo Diagnostics Selected by World Economic Forum as a 2026 Technology Pioneer - Yahoo Finance
Cardio Diagnostics Holdings (CDIO) Slips 2% as Shares Test Key Support Near $1.86Sentiment Extreme - newsline.com
Cardio Diagnostics Uses AI and Genetics to Improve Cardiovascular Risk Detection - citybuzz -
CDIO Q1 2025 Earnings: Narrower-Than-Expected Loss Lifts SharesQuarterly Profit Report - newsline.com
CDIO Q1 2025 Earnings: EPS Surprises to the Upside Despite No RevenueDebt Analysis Report - newsline.com
Cardio Diagnostics Stock Jumps as Tiny Heart-Test Firm Heads Into June Benefits Push - Bez Kabli
CDIO Q1 2025 Earnings: EPS Surpasses Estimates on Narrower Loss, Stock RisesGuidance Revision Trend - The Legal Advocate
CDIO Q1 2025 Earnings: EPS Surprise Beats Estimates by 47%, but Stock DeclinesEPS Guidance Update - newsline.com
CDIO Q1 2025 Earnings: EPS Surprise of 47% Highlights Improved Cost ManagementDividend Earnings Report - The Legal Advocate
CDIO Q1 2025 Earnings: Loss Narrows, Beats Estimates Amid Pre-Revenue StageMargin Improvement Report - The Legal Advocate
Cardio Diagnostics to Showcase AI-Powered Heart Risk Tools at Four Benefits Conferences - MEXC
Cardio Diagnostics Holdings Inc Stock (CDIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
0.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):